Skip to main content

Table 2 Hepatic differential metabolites and metabolic pathways in the different groups

From: Investigation of the idiosyncratic hepatotoxicity of Polygonum multiflorum Thunb. through metabolomics using GC-MS

No

t/min

Metabolites

m/z

Trend

Metabolic pathways

1

7.014

Propanoic acid

74.08

   

2

7.417

l-Valine

117.15

   

3

7.673

l-Alanine

89.09

↓1)

↓2)

Amino acid metabolism

4

7.988

Glycine

75.07

↑1)

 

Amino acid metabolism

5

8.267

Ethanedioic acid

90.03

 

↑2)

Oxalate metabolism

6

8.518

3-Hydroxybutyric acid

104.10

 

↑2)

Energetic metabolism

7

8.577

leucine

265.30

   

8

8.894

l-Isoleucine

131.17

   

9

9.964

Urea

60.06

   

10

10.133

Serine

105.09

   

11

10.277

Silanamine

80.59

   

12

10.386

Silanol

90.20

   

13

10.535

Hexadecane

260.65

   

14

10.732

L-Threonine

119.12

↑1)

 

Amino acid metabolism

15

10.982

Glycine

75.07

   

16

11.143

Butanedioic acid

118.09

   

17

11.424

Pyrimidine

80.09

   

18

11.667

2-Butenedioic acid

116.07

   

19

11.763

Serine

105.09

   

20

12.168

N, O, O-Tris (trimethylsilyl)-L-threonine

257.40

   

21

12.846

l-Aspartic acid,

133.10

   

22

13.541

Aminomalonic acid

119.08

   

23

13.851

Malic acid

134.09

   

24

13.968

Fructose benzoyl oxime

176.17

   

25

14.342

L-Aspartic acid

133.10

   

26

14.416

L-Proline

115.13

   

27

14.576

2-Pyrrolidone-5-carboxylic acid

151.10

   

28

15.892

Glutamine

169.11

   

29

16.675

D-Ribose

150.13

 

↑2)

Glucose metabolism

30

17.933

Phosphoric acid

98.00

 

↑2)

Amino acid metabolism

31

19.62

D-Mannose

182.17

↑1)

 

Glucose metabolism

32

19.845

D-Glucose

180.16

↑1)

 

Glucose metabolism

33

20.062

D-Galactose

180.16

   

34

21.887

Hexadecanoic acid

256.42

   

35

22.29

Inositol

180.16

   

36

22.76

D-Mannitol

182.17

   

37

22.837

Octadecane

254.49

   

38

23.898

Oleic acid

282.46

   

39

24.268

Octadecanoic acid

284.48

   

40

28.251

Hexadecanoic acid

256.42

 

↑2)

Fatty acid metabolism

  1. Notes: LPS model group (M) vs. negative control group, 1) p<0.01, lipopolysaccharide (LPS) + PM high dose group (CPHL) vs. LPS model group, 2) p<0.01. ↑-increase, ↓-decrease. Negative control group (C)